PPIP5K2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.527800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.726000E-01
Normal-vs-Stage2
2.849900E-02
Normal-vs-Stage3
7.326300E-02
Normal-vs-Stage4
4.315400E-01
Stage1-vs-Stage2
1.635600E-01
Stage1-vs-Stage3
9.916300E-02
Stage1-vs-Stage4
8.592200E-01
Stage2-vs-Stage3
2.372400E-01
Stage2-vs-Stage4
3.719200E-01
Stage3-vs-Stage4
1.075830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.580100E-02
Normal-vs-AfricanAmerican
2.557600E-01
Normal-vs-Asian
1.545960E-02
Caucasian-vs-AfricanAmerican
7.010800E-01
Caucasian-vs-Asian
8.584200E-02
AfricanAmerican-vs-Asian
1.405560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.577500E-02
Normal-vs-Female
6.576300E-02
Male-vs-Female
2.215800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.191000E-01
Normal-vs-Age(41-60Yrs)
1.256580E-01
Normal-vs-Age(61-80Yrs)
1.887620E-02
Normal-vs-Age(81-100Yrs)
8.263900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.731200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.962400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.702200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.209700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.905800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.256600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.257500E-02
Normal-vs-Daily Drinker
3.860300E-02
Normal-vs-Weekly Drinker
1.661040E-01
Normal-vs-Occasional Drinker
1.047390E-01
Normal-vs-Social Drinker
2.157000E-01
Non Drinker-vs-Daily Drinker
5.891200E-01
Non Drinker-vs-Weekly Drinker
6.783600E-01
Non Drinker-vs-Occasional Drinker
4.578400E-01
Non Drinker-vs-Social Drinker
6.150600E-01
Daily Drinker-vs-Weekly Drinker
4.729000E-01
Daily Drinker-vs-Occasional Drinker
2.895400E-01
Daily Drinker-vs-Social Drinker
3.938600E-01
Weekly Drinker-vs-Occasional Drinker
8.641400E-01
Weekly Drinker-vs-Social Drinker
8.982000E-01
Occasional Drinker-vs-Social Drinker
9.900600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.831600E-01
Normal-vs-Grade 2
5.807400E-01
Normal-vs-Grade 3
1.201440E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.324000E-01
Grade 1-vs-Grade 3
9.534400E-01
Grade 1-vs-Grade 4
2.831600E-01
Grade 2-vs-Grade 3
8.046000E-01
Grade 2-vs-Grade 4
5.807400E-01
Grade 3-vs-Grade 4
1.201440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.731600E-02
Normal-vs-NonDiabetic
2.229800E-02
Diabetic-vs-NonDiabetic
7.735600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.915210E-01
Normal-vs-NoPancreatitis
2.694000E-02
Pancreatitis-vs-NoPancreatitis
6.274500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.844200E-02
Normal-vs-N1
2.615700E-02
N0-vs-N1
7.700600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.937500E-02
Normal-vs-TP53-NonMutant
1.920400E-01
TP53-Mutant-vs-TP53-NonMutant
1.063400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
